Literature DB >> 28120465

Postoperative surgical-site hemorrhage after kidney transplantation: incidence, risk factors, and outcomes.

Laureen D Hachem1, Anand Ghanekar1,2, Markus Selzner1,2, Olusegun Famure1,3, Yanhong Li1, Sang Joseph Kim1,3,4.   

Abstract

Studies investigating the incidence, risk factors, and outcomes of surgical-site hemorrhage after kidney transplantation are limited. Patients who underwent a kidney transplant from 1 January 2000 to 30 September 2012 (followed until 31 December 2012) at Toronto General Hospital were included in this study. Postoperative surgical-site hemorrhage was defined as a drop in hemoglobin ≥20 g/l over a 24-hour period within 3 days of transplantation, followed by an ultrasound indicating a significant hematoma/collection. A total of 59 of 1203 (4.9%) kidney transplant recipients had postoperative surgical-site hemorrhage. Most cases (89.8%) occurred within 1 day after transplantation. Living donor transplants [OR 0.30 (95% CI: 0.16, 0.55)] and higher recipient BMI [OR 0.54 per 10 kg/m2 increase in BMI (95% CI: 0.30, 0.99)] were associated with a significantly lower risk of bleeding. Chronic preoperative anticoagulant usage led to an increased risk of bleeding but was not statistically significant [OR 1.75 (95% CI: 0.52, 5.88)]. Postoperative hemorrhage was associated with a higher risk of graft loss or death [HR 1.62 (95% CI: 1.01, 2.60)]. While the incidence of postoperative surgical-site hemorrhage in kidney transplantation is relatively low, it may be associated with an increased risk of graft loss or death.
© 2017 Steunstichting ESOT.

Entities:  

Keywords:  incidence; kidney transplant; outcomes; risk factors; surgical-site hemorrhage

Mesh:

Year:  2017        PMID: 28120465     DOI: 10.1111/tri.12926

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  5 in total

1.  One-year Allograft and Patient Survival in Renal Transplant Recipients Receiving Antiplatelet Therapy at the Time of Transplantation.

Authors:  T Benkö; M Gottmann; S Radunz; A Bienholz; F H Saner; J W Treckmann; A Paul; D P Hoyer
Journal:  Int J Organ Transplant Med       Date:  2018-02-01

2.  Very Early Cytomegalovirus Infection After Renal Transplantation: A Single-Center 20-Year Perspective.

Authors:  M R Jorgenson; J L Descourouez; B C Astor; J A Smith; F Aziz; R R Redfield; D A Mandelbrot
Journal:  Virology (Auckl)       Date:  2019-04-02

3.  Perioperative antithrombotic therapy does not increase the incidence of early postoperative thromboembolic complications and bleeding in kidney transplantation - a retrospective study.

Authors:  Tamar A J van den Berg; Robert C Minnee; Ton Lisman; Gertrude J Nieuwenhuijs-Moeke; Jacqueline van de Wetering; Stephan J L Bakker; Robert A Pol
Journal:  Transpl Int       Date:  2019-01-02       Impact factor: 3.782

4.  In vivo study for the hemostatic efficacy and foreign body reaction of a new powder-type polysaccharide hemostatic agent.

Authors:  Yoonhyeong Byun; Eun Jin Kim; Areum Lee; Young-Ah Suh; Hee Ju Sohn; Jung Min Lee; Jae Seung Kang; Yoo Jin Choi; Youngmin Han; Hongbeom Kim; Wooil Kwon; Jin-Young Jang
Journal:  Ann Surg Treat Res       Date:  2022-02-04       Impact factor: 1.859

5.  Predictive Value of HAS-BLED Score Regarding Bleeding Events and Graft Survival following Renal Transplantation.

Authors:  Hans Michael Hau; Markus Eckert; Sven Laudi; Maria Theresa Völker; Sebastian Stehr; Sebastian Rademacher; Daniel Seehofer; Robert Sucher; Tobias Piegeler; Nora Jahn
Journal:  J Clin Med       Date:  2022-07-12       Impact factor: 4.964

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.